JOURNAL OF ONCOLOGY PHARMACY PRACTICE

Scope & Guideline

Connecting research and practice in the fight against cancer.

Introduction

Welcome to your portal for understanding JOURNAL OF ONCOLOGY PHARMACY PRACTICE, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1078-1552
PublisherSAGE PUBLICATIONS LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1995 to 2024
AbbreviationJ ONCOL PHARM PRACT / J. Oncol. Pharm. Pract.
Frequency8 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND

Aims and Scopes

The JOURNAL OF ONCOLOGY PHARMACY PRACTICE focuses on optimizing pharmaceutical care in oncology, emphasizing the intersection of pharmacotherapy, patient safety, and clinical practice within cancer care. The journal aims to improve patient outcomes by disseminating research that addresses medication management, adverse drug reactions, and innovative pharmacy practices in oncology settings.
  1. Pharmaceutical Care in Oncology:
    The journal emphasizes the role of pharmacists in providing comprehensive medication management, ensuring safe and effective use of anticancer therapies, and enhancing patient education.
  2. Adverse Drug Reactions and Toxicity Management:
    Research on the identification, prevention, and management of adverse drug reactions related to cancer therapies, focusing on improving patient safety and quality of life.
  3. Clinical Pharmacy Interventions:
    The journal highlights studies on clinical pharmacy interventions, including medication reconciliation, therapeutic drug monitoring, and the integration of clinical pharmacists in oncology teams.
  4. Pharmacotherapy Research:
    The focus includes pharmacotherapy outcomes, including efficacy and safety of various cancer treatments, comparative effectiveness studies, and advancements in drug regimens.
  5. Patient-Centered Care:
    Research related to patient experience, adherence to medication, and the impact of educational interventions on cancer patients' knowledge and management of their therapies.
  6. Innovative Pharmacy Practices:
    Exploration of new methodologies in pharmacy practice, including the use of technology, telepharmacy, and automation in medication management for oncology patients.
The JOURNAL OF ONCOLOGY PHARMACY PRACTICE has increasingly shifted its focus towards emerging themes that reflect current challenges and advancements in oncology pharmacy. This trend showcases the journal's commitment to addressing contemporary issues in cancer care.
  1. Immunotherapy and Targeted Therapies:
    There is a growing emphasis on research related to immunotherapy and targeted therapies, reflecting their increasing use and complexity in cancer treatment.
  2. Pharmacogenomics and Personalized Medicine:
    Research into pharmacogenomics is on the rise, focusing on how genetic variations affect patient responses to cancer medications, promoting personalized treatment strategies.
  3. Telepharmacy and Remote Care:
    The incorporation of telepharmacy in oncology has gained traction, particularly in light of the COVID-19 pandemic, facilitating remote patient monitoring and medication management.
  4. Patient Education and Engagement:
    An increased focus on the importance of patient education and engagement strategies that enhance adherence and understanding of treatment protocols is evident.
  5. Management of Adverse Effects:
    Emerging research is increasingly centered on strategies to manage and mitigate adverse effects associated with modern cancer therapies, including immune-related adverse events.
  6. Cost-Effectiveness Studies:
    There is an upward trend in studies assessing the economic impact of cancer therapies, emphasizing the need for cost-effective treatment options in oncology.

Declining or Waning

In recent years, certain themes within the JOURNAL OF ONCOLOGY PHARMACY PRACTICE have seen a decline in focus, likely reflecting shifts in research priorities and emerging trends in oncology pharmacy practice.
  1. Traditional Chemotherapy Protocols:
    Research focused specifically on traditional chemotherapy regimens appears to be declining as newer targeted therapies and immunotherapies gain prominence.
  2. Single-Agent Studies:
    There is a noticeable decrease in publications centered on single-agent chemotherapy studies, as multi-agent and combination therapies become the focus of clinical research.
  3. Pharmacy Practice Guidelines:
    While guidelines remain important, there is a shift away from generic pharmacy practice guidelines towards more specific, evidence-based protocols tailored to individual patient needs.
  4. Focus on Pharmacokinetics Alone:
    Research that solely emphasizes pharmacokinetic studies without considering pharmacodynamics and clinical outcomes has seen less attention as a more holistic approach gains traction.
  5. Limited Scope on Complementary Therapies:
    Interest in complementary and alternative medicine approaches in oncology has waned, with a stronger emphasis on evidence-based pharmacotherapy.

Similar Journals

US PHARMACIST

Fostering Excellence in Pharmacy Through Research and Review
Publisher: JOBSON PUBLISHING LLCISSN: 0148-4818Frequency: 12 issues/year

US PHARMACIST, published by Jobson Publishing LLC, is a key resource in the field of pharmaceutical sciences and pharmacy, with a robust legacy dating back to 1979. The journal, identifiable by the ISSN 0148-4818 and E-ISSN 2331-3501, serves as a platform for sharing insightful research, critical reviews, and advancements that shape the industry and improve patient care. Although categorized in the fourth quartile for several aspects of pharmaceutical science and pharmacology, its targeted focus on pharmacy practice provides a unique perspective that is essential for practitioners and students alike. The journal offers an essential medium for continuous professional development, promoting knowledge dissemination among healthcare professionals. Given its dedication to enhancing pharmaceutical education and practice, it remains a vital tool for those engaged in the science and application of pharmacy. Notably, access options are not open, but subscribers can benefit from the journal's rich content focused on advancing the pharmacy field in the context of contemporary health challenges.

Pharmacy

Innovating drug development through open-access research.
Publisher: MDPIISSN: Frequency: 6 issues/year

Pharmacy is a premier open-access journal published by MDPI, dedicated to advancing research in the dynamic field of pharmaceutical sciences. Since its inception in 2013, this journal has become a vital platform for disseminating novel findings, reviews, and insights related to drug development, pharmacokinetics, pharmaceutical technology, and clinical applications. With an E-ISSN of 2226-4787, Pharmacy prioritizes accessibility and visibility, allowing researchers, professionals, and students from around the globe to engage with cutting-edge research without barriers. The journal plays a crucial role in shaping pharmaceutical education and practice, fostering innovative ideas and collaborative approaches aimed at improving health outcomes. As part of the MDPI family, Pharmacy is committed to maintaining high-quality standards, ensuring that all published articles undergo rigorous peer review.

Journal of Pharmacy and Bioallied Sciences

Innovating the Future of Pharmaceutical Sciences
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0976-4879Frequency: 6 issues/year

The Journal of Pharmacy and Bioallied Sciences is a premier open access publication that has been contributing to the fields of Pharmacy, Bioengineering, and Biochemistry since its establishment in India, under the esteemed Wolters Kluwer Medknow Publications. With the ISSN 0976-4879 and E-ISSN 0975-7406, this journal provides a platform for high-quality research articles, reviews, and clinical studies aimed at advancing knowledge and practice in the pharmaceutical and allied sciences. As a reflection of its academic stature, the journal holds a respectable categorization within the third and fourth quartiles in pertinent fields according to the latest metrics, with rankings that place it among prominent emerging research in pharmacology and biochemistry. Researchers and professionals are encouraged to access a wealth of knowledge freely, as the journal has been open access since 2010. The journal not only aims to foster innovative research but also strives to bridge the gap between pharmaceutical sciences and real-world applications, making it an essential resource for students, academics, and industry experts alike.

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Elevating health management through cutting-edge research.
Publisher: OXFORD UNIV PRESS INCISSN: 1079-2082Frequency: 24 issues/year

American Journal of Health-System Pharmacy, published by Oxford University Press Inc., stands as a vital resource in the domains of pharmacy and health policy. With an ISSN of 1079-2082 and E-ISSN 1535-2900, this esteemed journal provides a platform for disseminating high-quality research and insights that influence the practice of pharmacy and health management. The journal boasts a Q1 ranking in Pharmacy and ranks within the top quartiles in Health Policy and Medicine, reflecting its substantial impact on the field. With a comprehensive focus extending from 1995 to 2024, it caters to a diverse audience, including health professionals, researchers, and students interested in the ever-evolving dynamics of health-system pharmacy. Although it does not offer Open Access, the journal ensures that subscribers gain access to cutting-edge research essential for advancing health implications in pharmacy practice. By prioritizing innovative studies and reviews, the American Journal of Health-System Pharmacy plays a crucial role in shaping effective pharmaceutical care strategies and policies.

JOURNAL OF PHARMACY PRACTICE

Advancing pharmacy knowledge for a healthier tomorrow.
Publisher: SAGE PUBLICATIONS INCISSN: 0897-1900Frequency: 6 issues/year

JOURNAL OF PHARMACY PRACTICE, published by SAGE PUBLICATIONS INC, is a vital resource for researchers, pharmacy practitioners, and students dedicated to advancing the pharmacological and pharmaceutical sciences. Established in 1988, the journal serves as a platform for original research, reviews, and critical analyses in the fields of pharmacy and pharmacology. With an impressive impact factor and a strong presence in the Q2 category in Pharmacy and Q3 in Pharmacology (medical) as of 2023, it reflects the journal's commitment to delivering high-quality scholarly content that addresses pressing issues in pharmacy practice and medication management. The journal is indexed in Scopus, ranking #154 out of 272 in the field of Medicine and Pharmacology, positioning it within the 43rd percentile. Although it currently does not offer open access options, it remains an essential publication for those seeking to stay updated on innovations and best practices in the pharmacy sector, making it an indispensable tool for academic and professional growth.

Journal of Pharmaceutical Policy and Practice

Leading the way in pharmaceutical policy and practice innovation.
Publisher: TAYLOR & FRANCIS LTDISSN: Frequency: 1 issue/year

Journal of Pharmaceutical Policy and Practice, published by Taylor & Francis Ltd, is a premier open access journal dedicated to advancing the field of pharmaceutical policy and practice. Launched in 2013, this esteemed journal has rapidly become a vital resource for researchers, practitioners, and policymakers alike, offering a critical examination of health policies and their implementation in pharmaceutical contexts. With an impressive impact factor reflecting its significance, it ranks in the Q2 category for Health Policy and Q1 in both Pharmacology, Toxicology and Pharmaceutics and Pharmacy, showcasing its high-quality contributions to the field. Accessible to a global audience since 2014, the journal disseminates innovative research findings that inform best practices, foster policy development, and enhance patient outcomes in the pharmaceutical landscape. Positioned in the UK and with strong Scopus rankings, specifically ranked #3 in Health Professions (Pharmacy), the journal serves as an essential platform for those striving to navigate the ever-evolving intersection of healthcare and pharmaceutical sciences.

Journal of Young Pharmacists

Nurturing Insights, Shaping Pharmacological Futures
Publisher: INPHARM ASSOC, PHCOG NETISSN: 0975-1483Frequency: 4 issues/year

Journal of Young Pharmacists is a distinguished peer-reviewed journal published by INPHARM ASSOCIATION in collaboration with PHCOG NET. With an ISSN of 0975-1483 and an E-ISSN of 0975-1505, this journal serves as a vital platform for disseminating pioneering research in the field of pharmacology and toxicology. Although coverage in Scopus was discontinued in 2018, the journal continues to be important in educating future pharmacists and advancing the discipline, evident from its ranking in the 29th percentile among general pharmacology journals. The Journal of Young Pharmacists seeks to bridge the gap between theoretical knowledge and practical application, encouraging young researchers, professionals, and students to contribute their insights and findings. The journal emphasizes innovative approaches and contemporary issues relevant to the pharmaceutical sciences, making it an invaluable resource for anyone involved in this dynamic field.

JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

Bridging the gap between research and real-world application.
Publisher: FRONTIERS MEDIA SAISSN: Frequency: 1 issue/year

Welcome to the JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, a prestigious open access journal published by FRONTIERS MEDIA SA since 2008, dedicated to advancing research in the fields of pharmacy and pharmaceutical sciences. With its strong rooting in Canada, this journal has established itself within the academic community by consistently delivering high-quality studies and insights, as evidenced by its respectable Q2 ranking in both Medicine (miscellaneous) and Pharmaceutical Science categories for 2023, along with a notable 77th percentile ranking in Pharmaceutical Science on Scopus. Spanning over two decades of publication from 1998 to 2024, the journal focuses on critical research areas including pharmacology, toxicology, and drug development. By providing open access to its articles, the journal ensures that vital scientific information is readily available to researchers, professionals, and students alike, fostering collaboration and innovation within these essential disciplines. We invite you to explore the latest findings and contribute to the ongoing dialogue in pharmaceutical research through this essential platform.

Integrated Pharmacy Research and Practice

Uniting research and practice to elevate pharmaceutical standards.
Publisher: DOVE MEDICAL PRESS LTDISSN: 2230-5254Frequency: 1 issue/year

Integrated Pharmacy Research and Practice is a peer-reviewed, open-access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the field of pharmacy through innovative research and practice. With its ISSN 2230-5254, the journal has been providing a vital platform for disseminating new findings and best practices since its inception in 2012. Targeting researchers, practitioners, and students alike, it encompasses a broad scope that includes clinical pharmacy, drug regulation, and the socio-economic impact of pharmacy practices. Positioned in New Zealand's vibrant academic landscape, the journal aims to foster collaboration and knowledge sharing among professionals while upholding rigorous standards of scientific integrity. By offering unrestricted access to its content, Integrated Pharmacy Research and Practice plays a crucial role in shaping the future of pharmaceutical sciences and enhancing patient care globally.

Turkish Journal of Pharmaceutical Sciences

Empowering Researchers in Pharmaceutical Sciences
Publisher: GALENOS PUBL HOUSEISSN: 1304-530XFrequency: 6 issues/year

The Turkish Journal of Pharmaceutical Sciences, an esteemed publication by GALENOS PUBL HOUSE, has been a prominent platform for research and innovation in the fields of Pharmaceutical Sciences and Molecular Medicine since its inception as an Open Access journal in 2004. Based in Turkey, this journal serves as a vital resource for researchers, professionals, and students keen on exploring the latest advancements in drug development, pharmacology, and therapeutic innovations. With an ISSN of 1304-530X and an E-ISSN of 2148-6247, the journal is indexed in leading databases and has demonstrated strong rankings in the Scopus index, notably securing the second quartile in Pharmaceutical Sciences. Furthermore, it fosters academic collaboration and knowledge dissemination by making its content freely accessible. The journal aims to inspire groundbreaking research, providing an important academic forum for the dissemination of valuable insights that impact the pharmaceutical sector and contribute to global health.